It is important to be honest about the evidence base: much of the research on BPC-157 and thymosin beta-4 comes from preclinical and animal studies, and large long-term human trials are still limited
Antioxidants, 12 (9), 1724
10.1111/dom.13761 Summary Keywords anti-inflammatory, atherosclerosis, coronary artery disease, glucagon-like peptide-1, mechanisms Citation Skrobucha A, Pindlowski P, Krajewska N, Grabowski M and Jonik S (2024) Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review
Fiber intake must be deliberate
For a more powerful approach, professional treatments like peptide therapy deliver it directly where your body needs it most for regeneration
under the brand name Scenesse, an implantable form of afamelanotide has been approved in the EU, US, and elsewhere to reduce phototoxicity in erythropoietic protoporphyria (EPP)